Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.

BACK TO LIST

Patient
Name:	Hyam, Elizabeth
DOB:	01-SEP-1942 (Age: 83)
Gender:	female
Address:	74 Preston Rd TQ9 3SB Moreleigh (United Kingdom)
ID:	6284-190445-1

Report
Date:	03-AUG-2022

Laboratory

Requested by
Totnes Community Hospital TQ9 5 Totnes (United Kingdom)

Specimen
Collected:	02-AUG-2022

This seems not to be an HL7 Europe Laboratory Report (type coding LOINC 11502-2)

Chemistry

Test	02 Aug 2022	Reference Range	Unit
Hemoglobin A1c/Hemoglobin.total in Blood	5.4	4 - 6	%
Glucose [Mass/volume] in Blood	151.3 H	70 - 140	mg/dL
Urea nitrogen [Mass/volume] in Blood	17.2	7 - 43	mg/dL
Creatinine [Mass/volume] in Blood	0.5 L	0.6 - 1.1	mg/dL
Calcium [Mass/volume] in Blood	9.9	8.5 - 10.5	mg/dL
Sodium [Moles/volume] in Blood	143.7	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	5.2 H	3.5 - 5	mmol/L
Chloride [Moles/volume] in Blood	107.9	98 - 110	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	25.8	24 - 29	mmol/L
Cholesterol [Mass/volume] in Serum or Plasma	242.1 H	239 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	433.9 H	50 - 150	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	121.8	0 - 130	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	33.5 L	50 - 100	mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine	6.4	0 - 30	mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows impaired fasting glucose, hyperlipidemia (elevated total cholesterol and triglycerides, low HDL), and mild hyperkalemia. HbA1c is within target, suggesting no chronic hyperglycemia. Creatinine is slightly low, likely not clinically significant in the elderly. Renal function and microalbuminuria are unremarkable. Recommend further evaluation and management of dyslipidemia and glucose control.

Conclusion and Recommendations based on this report and previous findings known to us

The patient shows impaired fasting glucose, hyperlipidemia (elevated total cholesterol and triglycerides, low HDL), and mild hyperkalemia. HbA1c is within target, suggesting no chronic hyperglycemia. Creatinine is slightly low, likely not clinically significant in the elderly. Renal function and microalbuminuria are unremarkable. Recommend further evaluation and management of dyslipidemia and glucose control.